Biotech Profile Ocugen – Targeting 300,000 RP Patients with Gene-Agnostic Modifier Therapy Platform 4 November 2025
Biotech Profile Kindling Bio – Creating One Scalable Gene Therapy to Flag Multiple Childhood Tumors for Immune Destruction 31 October 2025
Biotech Profile Hemispherian – First-in-Class TET2 Agonist Tackles Glioblastoma Through DNA Demethylation 22 October 2025
Biotech Profile Citius Pharmaceuticals – From Late-Stage Development to Commercial Launch with FDA-Approved LYMPHIR™ 10 October 2025
Biotech Profile VERIGRAFT – First Industrially Scalable Personalised Tissue Therapy Platform Advances to Pivotal Phase II 12 September 2025
Biotech Profile GeoVax – From HIV Vaccine Pioneer to Multi-Platform Developer Targeting 40 Million Immunocompromised Americans 5 September 2025